September 19, 2012
Webinar
Managing Intellectual Property (MIP)
LexisNexis
Finnegan partner Eric Raciti will participate in a panel discussion regarding the impact of the Prometheus decision on the eligibility question, including what guidance it may provide with respect to the eligibility of gene patents, how the PTO is likely to react to the decision, and the impact the decision will have on the medical field. The Managing IP and LexisNexis co-hosted program will take place at 11:00 a.m. EDT. For more information, or to register, please see MIP’s website.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Conference
Boston Intellectual Property Law Association 4th Annual Symposium
April 10-11, 2024
Boston
Conference
Best Practices in Intellectual Property– A Decade of Dedication to IP Excellence
April 8-9, 2024
Tel Aviv
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.